\-\ Texto\\:\\ \ \(0\)\
\-\ painless\\ palpable\\ testicular\\ mass\\ within\\ the\\ left\\ testicle\\.\ \(0\)\
\-\ afp\\ \\ 3\\.3\\ ng\\/ml\\ \\(normal\\)\ \(0\)\
\-\ hcg\\ quantitative\\ less\\ than\\ 0\\.1\\ miu\\/ml\\ \\(normal\\)\ \(0\)\
\-\ ldh\\ 505\\ u\\/l\\ \\(normal\\)\ \(0\)\
\-\ pathologic\\ specimen\\ status\\ post\\ orchiectomy\\ demonstrated\\ a\\ mixed\\ germ\\ cell\\ tumor\\ with\\ a\\ \\ predominant\\ embryonal\\ carcinoma\\ component\\ and\\ a\\ smaller\\ yolk\\ sac\\ tumor\\ component\\ involving\\ less\\ than\\ 5\\%\\ of\\ the\\ testicle\\.\ \(0\)\
\-\ orchiectomy\\ for\\ testicular\\ mass\\.\\ \\ based\\ on\\ the\\ type\\ of\\ tumor\\ and\\ staging\\,\\ chemotherapy\\,\\ retroperitoneal\\ lymph\\ node\\ dissection\\,\\ surveillance\\,\\ and\\ radiation\\ therapy\\ can\\ be\\ performed\\.\ \(0\)\
\-\ within\\ the\\ mid\\ to\\ upper\\ pole\\ of\\ the\\ left\\ testicle\\,\\ there\\ is\\ a\\ heteroechoic\\ well\\ defined\\ mass\\ with\\ a\\ smaller\\ internal\\ hyperechoic\\ focus\\ demonstrating\\ posterior\\ shadowing\\.\\ \\ the\\ mass\\ in\\ the\\ left\\ testicle\\ measures\\ 1\\.6\\ cm\\ x\\ 1\\.8\\ cm\\ x\\ 1\\.7\\ cm\\.\\ \\ normal\\ testicular\\ blood\\ flow\\ was\\ seen\\ around\\ and\\ within\\ the\\ mass\\ on\\ color\\ doppler\\.\\ \\ additionally\\,\\ small\\ hydroceles\\ were\\ seen\\ around\\ both\\ testicles\\.\ \(0\)\
\-\ mixed\\ germ\\ cell\\ tumor\\ of\\ the\\ testicle\ \(0\)\
\-\ \\(embryonal\\ and\\ yolk\\ sac\\ tumor\\ components\\)\ \(0\)\
\-\ teratoma\ \(130\)\
\-\ yolk\\ sac\\ tumor\ \(8\)\
\-\ choriocarcinoma\ \(11\)\
\-\ burned\\ out\\ germ\\ cell\\ tumor\ \(0\)\
\-\ sex\\ cord\\-stromal\\ tumors\\ \\(leydig\\ cell\\ tumor\\ or\\ sertoli\\ cell\\ tumor\\)\ \(0\)\
\-\ seminoma\ \(37\)\
\-\ metastatic\\ disease\\ \\(prostate\\,\\ kidney\\,\\ lymphoma\\,\\ leukemia\\)\ \(0\)\
\-\ hematoma\ \(500\)\
\-\ orchitis\ \(17\)\
\-\ abscess\ \(594\)\
\-\ infarction\\ \ \(73\)\
\-\ granuloma\ \(235\)\
\-\ the\\ patient\\ presented\\ with\\ a\\ painless\\ left\\ testicular\\ mass\\.\ \(0\)\
\-\ nonseminomatous\\ tumors\\ such\\ as\\ the\\ one\\ in\\ this\\ case\\ most\\ often\\ occur\\ among\\ men\\ in\\ their\\ thirties\\.\\ \\ this\\ patient\\ was\\ slightly\\ younger\\ than\\ the\\ average\\ age\\ for\\ nonseminomatous\\ tumors\\ since\\ he\\ was\\ only\\ 23\\ years\\ old\\.\\ \\ testicular\\ tumors\\ are\\ the\\ most\\ common\\ malignancy\\ in\\ the\\ age\\ group\\ of\\ 15\\-35\\ years\\.\ \(0\)\
\-\ embryonal\\ carcinomas\\ are\\ more\\ aggressive\\ than\\ seminomas\\.\\ \\ only\\ 3\\%\\ of\\ nonseminomatous\\ germ\\ cell\\ tumors\\ are\\ pure\\ embryonal\\ carcinomas\\.\\ \\ around\\ 45\\%\\ of\\ mixed\\ germ\\ cell\\ tumors\\ contain\\ embryonal\\ components\\.\\ \\ this\\ patient\\â\\€\\™s\\ mixed\\ germ\\ cell\\ tumor\\ had\\ mixed\\ histologic\\ characteristics\\ involving\\ yolk\\ sac\\ tumor\\ and\\ embryonal\\ carcinoma\\.\\ \\ \ \(0\)\
\-\ this\\ patient\\â\\€\\™s\\ mixed\\ germ\\ cell\\ tumor\\ had\\ ultrasound\\ characteristics\\ which\\ are\\ typical\\ for\\ embryonal\\ carcinoma\\.\\ \\ embryonal\\ carcinomas\\ like\\ the\\ one\\ in\\ this\\ case\\ are\\ predominantly\\ hypoechoic\\ lesions\\ with\\ poorly\\ defined\\ margins\\ and\\ an\\ inhomogeneous\\ echotexture\\.\\ \\ this\\ tumor\\ also\\ had\\ echogenic\\ foci\\ within\\ it\\ which\\ often\\ represent\\ hemorrhage\\,\\ calcification\\,\\ or\\ fibrosis\\.\\ \\ the\\ mass\\ was\\ palpable\\ which\\ may\\ occur\\ with\\ embryonal\\ carcinomas\\ since\\ tumor\\ invasion\\ of\\ the\\ tunica\\ albuginea\\ is\\ common\\ and\\ may\\ distort\\ the\\ contour\\ of\\ the\\ testis\\.\\ \\ this\\ tumor\\ did\\ not\\ extend\\ beyond\\ the\\ tunica\\ vaginalis\\ though\\.\ \(0\)\
\-\ although\\ this\\ tumor\\ has\\ a\\ small\\ yolk\\ sac\\ tumor\\ component\\,\\ the\\ patient\\â\\€\\™s\\ afp\\ \\(alpha\\ fetoprotein\\)\\ level\\ was\\ not\\ elevated\\ or\\ abnormal\\.\\ \\ yolk\\ sac\\ tumors\\ are\\ frequently\\ seen\\ in\\ tumors\\ with\\ mixed\\ histologic\\ features\\ in\\ adults\\ and\\ indicate\\ a\\ poorer\\ prognosis\\.\\ \\ the\\ ultrasound\\ appearance\\ of\\ yolk\\ sac\\ tumors\\ is\\ consistent\\ with\\ the\\ inhomogeneous\\ appearance\\ and\\ echogenic\\ foci\\ seen\\ in\\ this\\ patient\\â\\€\\™s\\ tumor\\.\ \(0\)\
\-\ references\\:\ \(0\)\
\-\ 1\\.\\ \\ dogra\\ vs\\,\\ gottlieb\\ rh\\,\\ oka\\ m\\,\\ rubens\\ dj\\.\\ \\ sonography\\ of\\ the\\ scrotum\\.\\ \\ radiology\\ 2003\\;\\ 227\\:\\ 18\\-36\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ embryonal\\:\\ 0\\.3610893361059708\ \(0\)\
\-\ tumor\\:\\ 0\\.32256263513489236\ \(0\)\
\-\ yolk\\:\\ 0\\.2756928247839282\ \(0\)\
\-\ tumors\\:\\ 0\\.22677045769164678\ \(0\)\
\-\ germ\\:\\ 0\\.22395857149046522\ \(0\)\
\-\ sac\\:\\ 0\\.2135505871625057\ \(0\)\
\-\ mixed\\:\\ 0\\.19851842611567241\ \(0\)\
\-\ cell\\:\\ 0\\.17638644440239248\ \(0\)\
\-\ testicle\\:\\ 0\\.17231568453562865\ \(0\)\
\-\ the\\:\\ 0\\.1640683092140631\ \(0\)\
\-\ testicular\\:\\ 0\\.1606529362375449\ \(0\)\
\-\ carcinomas\\:\\ 0\\.15331316800492467\ \(0\)\
\-\ nonseminomatous\\:\\ 0\\.14457447682021338\ \(0\)\
\-\ this\\:\\ 0\\.10595223300105965\ \(0\)\
\-\ mass\\:\\ 0\\.09160575118089588\ \(0\)\
\-\ inhomogeneous\\:\\ 0\\.08910209567324134\ \(0\)\
\-\ component\\:\\ 0\\.08807925376436476\ \(0\)\
\-\ tunica\\:\\ 0\\.08805691707982058\ \(0\)\
\-\ around\\:\\ 0\\.0820353707924156\ \(0\)\
\-\ orchiectomy\\:\\ 0\\.07831604258649547\ \(0\)\
\-\ are\\:\\ 0\\.07800144879397565\ \(0\)\
\-\ than\\:\\ 0\\.07768485423369047\ \(0\)\
\-\ histologic\\:\\ 0\\.07665658400246234\ \(0\)\
\-\ of\\:\\ 0\\.07375056916783951\ \(0\)\
\-\ afp\\:\\ 0\\.07218001732861848\ \(0\)\
\-\ and\\:\\ 0\\.07079480132670757\ \(0\)\
\-\ in\\:\\ 0\\.0681828887008848\ \(0\)\
\-\ patient\\:\\ 0\\.06685901518122417\ \(0\)\
\-\ seen\\:\\ 0\\.06451796560245557\ \(0\)\
\-\ painless\\:\\ 0\\.06346007928881145\ \(0\)\
\-\ within\\:\\ 0\\.06311702739864991\ \(0\)\
\-\ characteristics\\:\\ 0\\.06283103629079304\ \(0\)\
\-\ echogenic\\:\\ 0\\.06283103629079304\ \(0\)\
\-\ components\\:\\ 0\\.0622333022200676\ \(0\)\
\-\ smaller\\:\\ 0\\.06166390765251879\ \(0\)\
\-\ carcinoma\\:\\ 0\\.06147896337072414\ \(0\)\
\-\ was\\:\\ 0\\.05970034111044428\ \(0\)\
\-\ cm\\:\\ 0\\.0590283083672883\ \(0\)\
\-\ foci\\:\\ 0\\.05600434051216887\ \(0\)\
\-\ normal\\:\\ 0\\.055953070913048276\ \(0\)\
\-\ rubens\\:\\ 0\\.0547897446302299\ \(0\)\
\-\ heteroechoic\\:\\ 0\\.05235452600689862\ \(0\)\
\-\ thirties\\:\\ 0\\.05235452600689862\ \(0\)\
\-\ distort\\:\\ 0\\.05235452600689862\ \(0\)\
\-\ dogra\\:\\ 0\\.05235452600689862\ \(0\)\
\-\ gottlieb\\:\\ 0\\.05235452600689862\ \(0\)\
\-\ oka\\:\\ 0\\.05235452600689862\ \(0\)\
\-\ had\\:\\ 0\\.05120928545304377\ \(0\)\
\-\ 505\\:\\ 0\\.05062671089673573\ \(0\)\
\-\ burned\\:\\ 0\\.05062671089673573\ \(0\)\
\-\ seminomas\\:\\ 0\\.05062671089673573\ \(0\)\
\-\ vaginalis\\:\\ 0\\.05062671089673573\ \(0\)\
\-\ occur\\:\\ 0\\.05039343504258817\ \(0\)\
\-\ since\\:\\ 0\\.049634531577142135\ \(0\)\
\-\ hydroceles\\:\\ 0\\.04928651337796013\ \(0\)\
\-\ defined\\:\\ 0\\.04888230050528232\ \(0\)\
\-\ poorer\\:\\ 0\\.048191492273404454\ \(0\)\
\-\ dj\\:\\ 0\\.048191492273404454\ \(0\)\
\-\ 227\\:\\ 0\\.048191492273404454\ \(0\)\
\-\ palpable\\:\\ 0\\.04813828711179027\ \(0\)\
\-\ involving\\:\\ 0\\.04799485882569117\ \(0\)\
\-\ pure\\:\\ 0\\.04726566512130737\ \(0\)\
\-\ with\\:\\ 0\\.04696022234612768\ \(0\)\
\-\ left\\:\\ 0\\.046747798878179175\ \(0\)\
\-\ which\\:\\ 0\\.04673555452610396\ \(0\)\
\-\ less\\:\\ 0\\.04661574863467374\ \(0\)\
\-\ albuginea\\:\\ 0\\.04646367716324157\ \(0\)\
\-\ rh\\:\\ 0\\.04512347964446597\ \(0\)\
\-\ often\\:\\ 0\\.04470974140405501\ \(0\)\
\-\ leydig\\:\\ 0\\.04402845853991029\ \(0\)\
\-\ sertoli\\:\\ 0\\.04354772298834105\ \(0\)\
\-\ age\\:\\ 0\\.043017963190222885\ \(0\)\
\-\ only\\:\\ 0\\.042807835798517976\ \(0\)\
\-\ choriocarcinoma\\:\\ 0\\.04268826102113469\ \(0\)\
\-\ ultrasound\\:\\ 0\\.04226482916592751\ \(0\)\
\-\ years\\:\\ 0\\.0420022618539133\ \(0\)\
\-\ appearance\\:\\ 0\\.041308464110153806\ \(0\)\
\-\ sex\\:\\ 0\\.041268512827820424\ \(0\)\
\-\ orchitis\\:\\ 0\\.041268512827820424\ \(0\)\
\-\ quantitative\\:\\ 0\\.0409604459109718\ \(0\)\
\-\ testicles\\:\\ 0\\.0409604459109718\ \(0\)\
\-\ fetoprotein\\:\\ 0\\.04038801410312651\ \(0\)\
\-\ one\\:\\ 0\\.039231307600450835\ \(0\)\
\-\ common\\:\\ 0\\.038859075735234214\ \(0\)\
\-\ predominant\\:\\ 0\\.03852522728764052\ \(0\)\
\-\ echotexture\\:\\ 0\\.03813760969625323\ \(0\)\
\-\ scrotum\\:\\ 0\\.03777349893770083\ \(0\)\
\-\ seminoma\\:\\ 0\\.03759940013554344\ \(0\)\
\-\ surveillance\\:\\ 0\\.037430206183084846\ \(0\)\
\-\ ldh\\:\\ 0\\.03726564826954603\ \(0\)\
\-\ testis\\:\\ 0\\.03710547909432626\ \(0\)\
\-\ specimen\\:\\ 0\\.03650437903098776\ \(0\)\
\-\ sonography\\:\\ 0\\.03636305514302878\ \(0\)\
\-\ among\\:\\ 0\\.036224980369632336\ \(0\)\
\-\ alpha\\:\\ 0\\.03609000866430924\ \(0\)\
\-\ younger\\:\\ 0\\.03582883759849943\ \(0\)\
\-\ or\\:\\ 0\\.03575568831354623\ \(0\)\
\-\ average\\:\\ 0\\.03570239107292195\ \(0\)\
\-\ beyond\\:\\ 0\\.03570239107292195\ \(0\)\
\-\ most\\:\\ 0\\.03566023838572465\ \(0\)\
\-\ small\\:\\ 0\\.03534527602474312\ \(0\)\
\-\ staging\\:\\ 0\\.03499498755975357\ \(0\)\
\-\ men\\:\\ 0\\.034884782850856735\ \(0\)\
\-\ indicate\\:\\ 0\\.034884782850856735\ \(0\)\
\-\ may\\:\\ 0\\.03448176833152964\ \(0\)\
\-\ case\\:\\ 0\\.03442404608568844\ \(0\)\
\-\ contain\\:\\ 0\\.03426291876295639\ \(0\)\
\-\ prostate\\:\\ 0\\.0331843299206959\ \(0\)\
\-\ retroperitoneal\\:\\ 0\\.03302199603537075\ \(0\)\
\-\ shadowing\\:\\ 0\\.03302199603537075\ \(0\)\
\-\ group\\:\\ 0\\.03255976893642228\ \(0\)\
\-\ hcg\\:\\ 0\\.03213058724750898\ \(0\)\
\-\ adults\\:\\ 0\\.03199408164149503\ \(0\)\
\-\ extend\\:\\ 0\\.03160224784205649\ \(0\)\
\-\ hyperechoic\\:\\ 0\\.03153935733942779\ \(0\)\
\-\ leukemia\\:\\ 0\\.031294180925207866\ \(0\)\
\-\ for\\:\\ 0\\.031152139756375697\ \(0\)\
\-\ dissection\\:\\ 0\\.0311166511100338\ \(0\)\
\-\ granuloma\\:\\ 0\\.031001147778717993\ \(0\)\
\-\ poorly\\:\\ 0\\.03094421855511206\ \(0\)\
\-\ color\\:\\ 0\\.03088782388609883\ \(0\)\
\-\ contour\\:\\ 0\\.030831953826259396\ \(0\)\
\-\ 2003\\:\\ 0\\.030831953826259396\ \(0\)\
\-\ doppler\\:\\ 0\\.03066739591272058\ \(0\)\
\-\ invasion\\:\\ 0\\.030560143274722396\ \(0\)\
\-\ prognosis\\:\\ 0\\.030149317309517275\ \(0\)\
\-\ predominantly\\:\\ 0\\.030002224534242835\ \(0\)\
\-\ pole\\:\\ 0\\.029858648259937424\ \(0\)\
\-\ though\\:\\ 0\\.029764802786203342\ \(0\)\
\-\ teratoma\\:\\ 0\\.02962672801280689\ \(0\)\
\-\ aggressive\\:\\ 0\\.02962672801280689\ \(0\)\
\-\ node\\:\\ 0\\.029447431470712493\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.029273332668555106\ \(0\)\
\-\ margins\\:\\ 0\\.029230585241673993\ \(0\)\
\-\ focus\\:\\ 0\\.029021296187201735\ \(0\)\
\-\ fibrosis\\:\\ 0\\.02870090086070981\ \(0\)\
\-\ represent\\:\\ 0\\.028508999931780778\ \(0\)\
\-\ their\\:\\ 0\\.028433924102691167\ \(0\)\
\-\ demonstrating\\:\\ 0\\.02825024042517718\ \(0\)\
\-\ 23\\:\\ 0\\.02825024042517718\ \(0\)\
\-\ additionally\\:\\ 0\\.028214168316008908\ \(0\)\
\-\ frequently\\:\\ 0\\.028214168316008908\ \(0\)\
\-\ is\\:\\ 0\\.02814728189217812\ \(0\)\
\-\ pathologic\\:\\ 0\\.028072008114169534\ \(0\)\
\-\ measures\\:\\ 0\\.027933135149779506\ \(0\)\
\-\ features\\:\\ 0\\.027567005910911557\ \(0\)\
\-\ 45\\:\\ 0\\.02747090805083104\ \(0\)\
\-\ radiology\\:\\ 0\\.027439214108562326\ \(0\)\
\-\ references\\:\\ 0\\.027314084830083525\ \(0\)\
\-\ not\\:\\ 0\\.02705033574865012\ \(0\)\
\-\ infarction\\:\\ 0\\.026895588054364386\ \(0\)\
\-\ slightly\\:\\ 0\\.02672479015260467\ \(0\)\
\-\ lymph\\:\\ 0\\.026641178758814478\ \(0\)\
\-\ typical\\:\\ 0\\.026477368928744565\ \(0\)\
\-\ vs\\:\\ 0\\.026137069440137398\ \(0\)\
\-\ malignancy\\:\\ 0\\.025648508495770737\ \(0\)\
\-\ like\\:\\ 0\\.025463694279312724\ \(0\)\
\-\ based\\:\\ 0\\.024817265788571068\ \(0\)\
\-\ mid\\:\\ 0\\.024656021523735548\ \(0\)\
\-\ did\\:\\ 0\\.024576994224049933\ \(0\)\
\-\ calcification\\:\\ 0\\.02446036943103311\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.02432710907723103\ \(0\)\
\-\ kidney\\:\\ 0\\.024069143555895137\ \(0\)\
\-\ hematoma\\:\\ 0\\.023979633879463877\ \(0\)\
\-\ status\\:\\ 0\\.023908974380675366\ \(0\)\
\-\ elevated\\:\\ 0\\.02335573104960682\ \(0\)\
\-\ although\\:\\ 0\\.023323784228951414\ \(0\)\
\-\ internal\\:\\ 0\\.02308945067840818\ \(0\)\
\-\ type\\:\\ 0\\.022983147228578287\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.02293815834314443\ \(0\)\
\-\ flow\\:\\ 0\\.02281980992029159\ \(0\)\
\-\ radiation\\:\\ 0\\.02270374856722286\ \(0\)\
\-\ out\\:\\ 0\\.022519805225575684\ \(0\)\
\-\ such\\:\\ 0\\.022037997846017104\ \(0\)\
\-\ abscess\\:\\ 0\\.02199953887924134\ \(0\)\
\-\ demonstrated\\:\\ 0\\.021055484131598638\ \(0\)\
\-\ level\\:\\ 0\\.020695228720213406\ \(0\)\
\-\ on\\:\\ 0\\.020694422432510188\ \(0\)\
\-\ abnormal\\:\\ 0\\.020583154443014364\ \(0\)\
\-\ lymphoma\\:\\ 0\\.020404154793483974\ \(0\)\
\-\ he\\:\\ 0\\.020287718420668333\ \(0\)\
\-\ performed\\:\\ 0\\.020268529943891583\ \(0\)\
\-\ presented\\:\\ 0\\.019978690622588578\ \(0\)\
\-\ blood\\:\\ 0\\.019897098585718222\ \(0\)\
\-\ therapy\\:\\ 0\\.019684788239810572\ \(0\)\
\-\ lesions\\:\\ 0\\.0196761027890961\ \(0\)\
\-\ both\\:\\ 0\\.019105249220156842\ \(0\)\
\-\ more\\:\\ 0\\.01881259190597036\ \(0\)\
\-\ metastatic\\:\\ 0\\.018790083491909682\ \(0\)\
\-\ post\\:\\ 0\\.018642145270615917\ \(0\)\
\-\ consistent\\:\\ 0\\.01857674366476182\ \(0\)\
\-\ upper\\:\\ 0\\.018308195933408294\ \(0\)\
\-\ can\\:\\ 0\\.01797874186722449\ \(0\)\
\-\ posterior\\:\\ 0\\.017716318118518835\ \(0\)\
\-\ were\\:\\ 0\\.017660216109034774\ \(0\)\
\-\ it\\:\\ 0\\.017537389985449077\ \(0\)\
\-\ well\\:\\ 0\\.01658902626611202\ \(0\)\
\-\ also\\:\\ 0\\.01611508278565283\ \(0\)\
\-\ has\\:\\ 0\\.015649125755620847\ \(0\)\
\-\ disease\\:\\ 0\\.01438127427301437\ \(0\)\
\-\ be\\:\\ 0\\.013898050911348521\ \(0\)\
\-\ as\\:\\ 0\\.013763595111572416\ \(0\)\
\-\ there\\:\\ 0\\.013632083575218635\ \(0\)\
\-\ an\\:\\ 0\\.013101039604407708\ \(0\)\
\-\ old\\:\\ 0\\.010139683094530248\ \(0\)\
\-\ to\\:\\ 0\\.00856501808890543\ \(0\)\
